Tetsuro Marunouchi

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Tanshinone VI Attenuates the Development of Heart Failure with Preserved Ejection Fraction in Mice.

Tanshinone VI Attenuates the Development of Heart Failure with Preserved Ejection Fraction in Mice.

Journal: Biological & pharmaceutical bulletin

Published: January 04, 2026

Treatment with anti-Hsp90 antibody mitigates fibronectin-related cardiac fibrosis induced by pressure overload in mice.

Treatment with anti-Hsp90 antibody mitigates fibronectin-related cardiac fibrosis induced by pressure overload in mice.

Journal: Biochemical pharmacology

Published: October 08, 2025

Tanshinone VI Induces Cardiac Differentiation of Cardiosphere-Derived Cells Prepared from Rat Hearts.

Tanshinone VI Induces Cardiac Differentiation of Cardiosphere-Derived Cells Prepared from Rat Hearts.

Journal: Biological & pharmaceutical bulletin

Published: August 27, 2025

Gemfibrozil mitigates caspase-11-driven myocardial pyroptosis in ischemia/reperfusion injury in mice.

Gemfibrozil mitigates caspase-11-driven myocardial pyroptosis in ischemia/reperfusion injury in mice.

Journal: Journal of molecular and cellular cardiology plus

Published: January 17, 2025

Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis.

Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis.

Journal: Biochemical pharmacology

Published: July 23, 2024

Angiotensin II Is Involved in MLKL Activation During the Development of Heart Failure Following Myocardial Infarction in Rats.

Angiotensin II Is Involved in MLKL Activation During the Development of Heart Failure Following Myocardial Infarction in Rats.

Journal: Biological & pharmaceutical bulletin

Published: April 07, 2024

Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.

Simvastatin Attenuates Cardiac Fibrosis under Pathophysiological Conditions of Heart Failure with Preserved Left Ventricular Ejection Fraction by Inhibiting TGF-β Signaling.

Journal: Pharmacology

Published: May 30, 2023

Involvement of Hsp90 in NLRP3 inflammasome activation in the failing heart following myocardial infarction in rats.

Involvement of Hsp90 in NLRP3 inflammasome activation in the failing heart following myocardial infarction in rats.

Journal: Biochemical pharmacology

Published: February 04, 2023

Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.

Simvastatin attenuates the c-Raf/Erk and calcineurin-NFATc2 pathways via inhibition of Hsp90 activity during the development of heart failure.

Journal: Journal of pharmacological sciences

Published: July 16, 2022

Effects of 17-AAG on the RIP1/RIP3/MLKL pathway during the development of heart failure following myocardial infarction in rats.

Effects of 17-AAG on the RIP1/RIP3/MLKL pathway during the development of heart failure following myocardial infarction in rats.

Journal: Journal of pharmacological sciences

Published: April 14, 2021

Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways.

Hsp90 Inhibitor Attenuates the Development of Pathophysiological Cardiac Fibrosis in Mouse Hypertrophy via Suppression of the Calcineurin-NFAT and c-Raf-Erk Pathways.

Journal: Journal of cardiovascular pharmacology

Published: December 17, 2020

Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.

Effects of Hsp90 inhibitor on the RIP1-RIP3-MLKL pathway during the development of heart failure in mice.

Journal: European journal of pharmacology

Published: October 01, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026